Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamarit

Showing results (551-560 of 620) with videos related to

Pageof 62
Sort By:
Journal of Clinical Lipidology|October 9, 2023
Impact of conducting a genetic study on the management of familial hypercholesterolemiaVictoria Marco-Benedí, Ana Cenarro, Àlex Vila, et al.
Cell Reports|October 7, 2015
GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate DistributionMelis Karaca, Francesca Frigerio, Stephanie Migrenne, et al.
Psychological Reports|May 9, 2022
Social and Psychological Effects of COVID-19 Pandemic on Adolescents' and Young Adults' Mental Health: A Cross-Cultural Mediation StudyKonstanze Schoeps, Alicia Tamarit, Usue De la Barrera, et al.
Revista Clinica Espanola|November 21, 2019
Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia? The MEJORALO-CV ProjectV Giner Galvañ, I Bonig Trigueros, L Fácila Rubio, et al.
Frontiers in Immunology|July 2, 2026
Correction: VTX-PID as a novel recombinant immunoglobulin G-degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE studyBernard Benichou, Rainard Fuhr, Elodie Vernadal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2024
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia PatientsBerta Alemany-Perna, Jordi Tamarit, Elisa Cabiscol, et al.
Transplant Immunology|April 23, 2016
New strategy of tacrolimus administration in animal model based on tacrolimus-loaded microspheresJose J Zamorano-Leon, Ines Hernandez-Fisac, Sandra Guerrero, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 20, 2008
[Recurrent reversible acute renal failure in a patient with hematuria and Schönlein-Henoch purpura]E Torregrosa de Juan, J Hernández Jaras, J J Sánchez Canell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 16, 2002
Early malnutrition and programming of adult degenerative diseases: experimental, epidemiological and preventive studiesC Remacle, B Reusens, L Kalbe, et al.
Frontiers in Immunology|June 5, 2026
VTX-PID as a novel recombinant immunoglobulin G-degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE studyBernard Benichou, Rainard Fuhr, Elodie Vernadal, et al.
Pageof 62

Showing results (551-560 of 620) with videos related to

Sort By:
Pageof 62
Journal of Clinical Lipidology|October 9, 2023
Impact of conducting a genetic study on the management of familial hypercholesterolemiaVictoria Marco-Benedí, Ana Cenarro, Àlex Vila, et al.
Cell Reports|October 7, 2015
GDH-Dependent Glutamate Oxidation in the Brain Dictates Peripheral Energy Substrate DistributionMelis Karaca, Francesca Frigerio, Stephanie Migrenne, et al.
Psychological Reports|May 9, 2022
Social and Psychological Effects of COVID-19 Pandemic on Adolescents' and Young Adults' Mental Health: A Cross-Cultural Mediation StudyKonstanze Schoeps, Alicia Tamarit, Usue De la Barrera, et al.
Revista Clinica Espanola|November 21, 2019
Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidaemia influenced the management of dyslipidaemia? The MEJORALO-CV ProjectV Giner Galvañ, I Bonig Trigueros, L Fácila Rubio, et al.
Frontiers in Immunology|July 2, 2026
Correction: VTX-PID as a novel recombinant immunoglobulin G-degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE studyBernard Benichou, Rainard Fuhr, Elodie Vernadal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2024
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia PatientsBerta Alemany-Perna, Jordi Tamarit, Elisa Cabiscol, et al.
Transplant Immunology|April 23, 2016
New strategy of tacrolimus administration in animal model based on tacrolimus-loaded microspheresJose J Zamorano-Leon, Ines Hernandez-Fisac, Sandra Guerrero, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|November 20, 2008
[Recurrent reversible acute renal failure in a patient with hematuria and Schönlein-Henoch purpura]E Torregrosa de Juan, J Hernández Jaras, J J Sánchez Canell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 16, 2002
Early malnutrition and programming of adult degenerative diseases: experimental, epidemiological and preventive studiesC Remacle, B Reusens, L Kalbe, et al.
Frontiers in Immunology|June 5, 2026
VTX-PID as a novel recombinant immunoglobulin G-degrading enzyme (IdeS) for efficient AAV-based gene therapy in participants with neutralizing antibodies: results of the phase I first-in-human NAVIgATE studyBernard Benichou, Rainard Fuhr, Elodie Vernadal, et al.
Pageof 62